About Optos

Optos develops ultra-widefield retinal imaging devices that capture 200 degrees of the retina in a single shot, enabling eye care professionals to detect and manage retinal diseases earlier and more effectively. Founded after a child's preventable vision loss, the company has transformed diagnostic capabilities for millions of patients across 30,000 locations worldwide. The optomap imaging systems, including Silverstone RGB and MonacoPro devices with integrated OCT technology, support early detection of retinal detachments, glaucoma, diabetic retinopathy, and macular degeneration. Backed by over 4,000 clinical studies, Optos provides comprehensive diagnostic tools that improve patient outcomes.